MS in the 21st Century (MS21) leads the conversation on COVID-19 vaccination and MS

Written by Merck KGaA (Darmstadt, Germany)

With the availability of COVID-19 vaccinations increasing globally, many in the multiple sclerosis (MS) community are asking for answers to two key questions: is the vaccine safe for me, and do I need to make any changes to my treatment plan?

Currently the supply of peer-reviewed data on the topic of MS and COVID-19 vaccinations is limited; however, in contrast, there is a vast amount of (often conflicting) online conversation, causing confusion and concern for the MS community.

MS in the 21st Century (MS21) is a Merck KGaA (Darmstadt, Germany) initiative comprising a steering group of expert healthcare professionals (HCPs) and people with MS (PwMS) from across the world, and over the last few weeks, they have collated answers to some of the most common patient questions and concerns around COVID-19 vaccinations and MS.

To better understand how to manage your MS treatment and the COVID-19 vaccine, watch their ‘FAQ’ video below or download the content from their website:

Should you have any further questions or concerns regarding your MS treatment and the COVID-19 vaccine, your healthcare team support is the best source of reliable information about your individual treatment plan.

In association with:

UI-NONNI-00152 April-2021